Series A · Biotech

Dash Bio raises $30M Series A

Dash Bio raised $30 million in Series A financing announced in August.

Oak HC/FT, Freestyle Capital and Swift Ventures are among its backers. The company provides automated bioanalysis for drug testing.

Funding history

Series A · This round$30M

Sources

  1. Dash Bioprojectstartups.com
  2. businesswire.com